newsfilter
← Latest News
Business Wire·

AlloVir to Present at Upcoming Investor Conferences

AlloVir, Inc. (NASDAQ:ALVR), a late-clinical stage allogeneic T cell immunotherapy company, today announced that Diana Brainard, M.D., Chief Executive Officer, will participate in the following upcoming investor